Avalanche Bio soars after raising $102M in upsized IPO
July 31, 2014 at 09:06 AM EDT
Stock in Avalanche Biotechnologies, an eye disease-treatment company, soared Thursday after it hit the top of its target range with a $102 million IPO...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.